European Journal of Internal Medicine
Volume 19, Issue 3 , Pages 209-213, May 2008

Classical cardiovascular risk factors according to fasting plasma glucose levels

  • Sergio Martinez-Hervas

      Affiliations

    • Endocrinology Service, University Clinical Hospital, Department of Medicine—University of Valencia, Spain
    • Corresponding Author InformationCorresponding author. S. Endocrinología, Hospital Clínico Universitario de Valencia, Avda Blasco Ibanez 17, 46010 Valencia, Spain. Tel.: +34 96 3862665; fax: +34 96 3862665.
  • ,
  • Pedro Romero

      Affiliations

    • Center for Primary Care, Valencia, Spain
  • ,
  • Enrique B. Hevilla

      Affiliations

    • Department of Preventive Medicine and Public Health, University of Valencia & University Clinical Hospital, Valencia, Spain
  • ,
  • José T. Real

      Affiliations

    • Endocrinology Service, University Clinical Hospital, Department of Medicine—University of Valencia, Spain
  • ,
  • Antonia Priego

      Affiliations

    • Endocrinology Service, University Clinical Hospital, Department of Medicine—University of Valencia, Spain
  • ,
  • Jose M. Martin-Moreno

      Affiliations

    • Department of Preventive Medicine and Public Health, University of Valencia & University Clinical Hospital, Valencia, Spain
  • ,
  • Rafael Carmena

      Affiliations

    • Endocrinology Service, University Clinical Hospital, Department of Medicine—University of Valencia, Spain
  • ,
  • Juan F. Ascaso

      Affiliations

    • Endocrinology Service, University Clinical Hospital, Department of Medicine—University of Valencia, Spain

Received 24 April 2007; received in revised form 29 June 2007; accepted 27 September 2007. published online 09 November 2007.

Abstract 

Background

To compare the prevalence of classical cardiovascular risk factors (CVRF) and metabolic syndrome (MetS) in our population according to fasting plasma glucose levels (FPG).

Methods

We have studied 344 subjects between 20–70 years of age, recruited in a Primary Care Clinic. Subjects were divided into four groups according to their fasting plasma glucose (FPG) values: normal plasma glucose (NG) when FPG<5.6 mmol/L; FPG between 5.6 and 6.0 mmol/L (FPG1); FPG between 6.1–6.9 mmol/L (FPG2); and diabetes (DM) FPG7 mmol/L or previous diagnosis of diabetes. Cardiovascular risk factors (hypertension, TC/HDL-C index and Apo B values), presence of the MetS and indirect measure of insulin resistance (HOMA) were analyzed.

Results

Subjects with FPG2 have a prevalence of classic CVRF and MetS similar to that observed in subjects with type 2 diabetes mellitus (T2DM). The TC:HDL-C index5 in 56% and 57%, Apo B1.2 g/L in 59% and 57%, hypertension in 60% and 54% of FPG2 and T2DM subjects, respectively. MetS was diagnosed in 79% of FPG2 and 80% of T2DM. We found significant differences with FPG1 group who presented low CVRF and MetS proportion.

Conclusion

In our population FPG2 and T2DM subjects show a similar cardiovascular risk profile. On the other hand, such risk is significantly lower in subjects with FPG between 5.6–6.0 mmol/L. These results might have practical implications.

Keywords: Impaired fasting glucose, Metabolic syndrome, Cardiovascular risk factors

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0953-6205(07)00264-6

doi:10.1016/j.ejim.2007.09.005

European Journal of Internal Medicine
Volume 19, Issue 3 , Pages 209-213, May 2008